Effect Of Iron Deficiency Anemia Research Articles

Effect of Iron Deficiency Anemia on Fetal and Maternal Morbidity

Effect of Iron Deficiency Anemia on Fetal and Maternal Morbidity

A Single-group, Clinical Interventional Study on the Effect of Iron Deficiency Anemia on Blood Glucose and Insulin Resistance in Women with Type II Diabetes.

Iron deficiency anemia (IDA) is one of the disorders recently associated with an increase in insulin resistance (IR) and, consequently, diabetes mellitus (DM) affection by causing oxidative stress. In this study, we look at how IDA may contribute to developing type II diabetes mellitus (T2DM), controlling diabetes, and reducing IR in women with T2DM. In this single group, clinical interventional study, we enrolled 40 women with T2DM and IDA. Before and after intervention with ferrous sulfate tablets, their blood glucose (BG) levels and IR levels were evaluated. This study was approved by the Ethics Committee of Qom University of Medical Sciences (ethics code: IR.MUQ.REC.1397.031) and registered at the Iranian Center for Clinical Trials (No. IRCT20170215032587N3). A significant level was considered p <0.05. The mean age of patients was 48.18 ± 4.6 years, with 5.3-5.8 years duration of T2DM. After the intervention, the mean fasting blood glucose (FBG) level reached 198.53 ± 48.11 to 170.93 ± 37.41, which was significant (p <0.0001). Also, hemoglobin A1C level reached from 8.49 ± 0.9 to 7.96 ± 0.58, which was significant (p <0.0001). Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) demonstrating a significant reduction of IR levels after intervention with ferrous sulfate tablets (p <0.018). IDA treatment in patients with T2DM can significantly reduce the BG and IR levels. To better control BG, checking iron status and its correction may provide better clinical outcomes in these patients. IRCT20170215032587N3.

The effect of iron deficiency anemia on myocardial function in pediatrics

BackgroundIron deficiency is one of the most common types of anemia in children. Anemia leads to tissue hypoxia, which activates compensatory mechanisms such as increased cardiac output. Tissue Doppler imaging (TDI) is a useful echocardiographic technique for evaluation of regional and global myocardial systolic and diastolic function. ObjectivesThis study aimed to determine whether iron deficiency anemia (IDA) affects myocardial function in pediatric patients using conventional echocardiography and TDI. MethodsThis case-control study was conducted at an outpatient general pediatric clinic in cooperation with the Cardiology Unit of the Pediatric Department of Fayoum University Hospital from May 2021 to February 2022. The study included 30 cases with IDA and 30 apparently healthy children. The two study groups were matched for age and sex. ResultsThere was an increase in left ventricular end-diastolic diameter (LVEDD), while the control group showed increased ejection time (ET). There was a statistically significant lower mean E/A ratio among cases. There was a positive correlation between serum iron levels, ET, and isovolumetric contraction time (IVCT) among the cases. Additionally, there was a negative correlation between hemoglobin levels and LVEDD in the entire study group. No significant difference was found between the two study groups regarding the Tei index. ConclusionMinimal alterations in LV function parameters may occur due to IDA. A decrease in serum iron levels was significantly associated with further decreases in ET and IVCT. Additionally, there was a statistically significant lower mean E/A ratio among cases.

Evaluation of Effect of Iron Deficiency Anemia on HbA2 Levels

Objective: To evaluate the effect of iron deficiency anemia on HbA2 levels. Study Design: Comparative cross-sectional study. Place and Duration of Study: Department of Pathology, Combined Military Hospital, Lahore Pakistan, from Jan to Oct 2020. Methodology: A total of 206 subjects were included in the study out of which 56 served as healthy controls. Five milliliters of whole blood were extracted in an EDTA tube and basic haematological parameters were performed using automated hematology analyzer (Sysmex KX-21). HbA2 levels were determined by cellulose acetate hemoglobin electrophoresis at alkaline pH (Mini Hor-8). Serum Ferritin levels were measured by chemiluminescence on Cobas e411 and Serum Iron levels by spectrophotometric method using ferrozine (Cobas c501). Results: Mean hemoglobin in control group was 12.5±0.7 g/dL and in iron deficiency anemia group was 8.1±1.36 g/dL (p=0.01). Mean HbA2 level in control group was 2.69±0.24% and iron deficiency anemia group was 1.76±0.25 % (p=0.001). HbA2 levels were reduced in individuals having haemoglobin levels less than 10g/dL and remained unchanged/minimally changed with hemoglobin levels reaching near normal levels. Conclusion: There was a statistically significant association of HbA2 levels with degree of anemia and serum ferritin levels (p=0.001).

Impact of anemia on HbAC level in type 2 diabetes mellitus patients

HbA1c is one of the important laboratory markers of blood glucose levels monitoring over last 2-3 months. Studies have shown that many factors affect HbA1c levels, hence it is not the only investigation to diagnose diabetes mellitus. As both iron deficiency anaemia and diabetes mellitus are highly prevalent disorders, effect of iron deficiency anaemia on HbA1C need to be evaluated. Many factors such as haemolytic anaemia, vitamin deficiencies, pregnancy. Kidney disease, haemoglobin variants can affect HbA1C levels. This study had two groups of participants. Group 1 included diabetic patients with iron deficiency anaemia and group 2 included diabetic patients without iron deficiency anaemia. Significant correlation between HbA1C and iron deficiency anaemia has been found. PCV, MCH, MCHC, MCV are low in diabetics with Iron deficiency anaemia and high in diabetics without iron deficiency anaemia. Need for anaemia screening before treatment planning of diabetes based on HBA1C levels must be considered and for optimal diabetes control, treating anemia is necessary.

Assessment of Serum Electrolytes and Glycated Hemoglobin Level in Non-diabetic Iron-Deficient Anaemic Patients.

The WHO has recognised iron deficiency anaemia (IDA) as the most common nutritional deficiency in the world, with 30% of the population being affected by this condition. The patient's glycemic status during the past three months is shown by the glycated haemoglobin A1C (HbA1c) test. According to several studies, iron deficiency can increase HbA1C levels without affecting blood sugar levels. HbA1C levels of≥6.5% have been approved by the American Diabetes Association (ADA) as a diagnostic indicator for diabetes mellitus (DM). An imbalance in serum electrolyte levels and anaemia havebeenlinked by several studies. Aim: To analyze the effect of iron deficiency anaemia on HbA1c levels and serum electrolytes in an adult non-diabetic population. This was a descriptive cross-sectional studyconducted in Shri BM Patil Medical College, Hospital and Research Centre, Vijayapura, Karnataka, India from January 2021 to June 2022. A total of 65 moderate to severe normoglycemic iron deficiency anemia patients between 18 to 75 years were enrolled in the studyafter fulfilling inclusion and exclusion criteria. A detailed history, clinical and biochemical examination was performed including HbA1c levels. The results were pooled and statistical analyses were performed using Statistical Package for Social Sciences (SPSS) version 20 (IBM Corp., Armonk, NY, USA). We found elevated HbA1c levels (5.67±1.1%) in non-diabetic iron-deficient anaemia individuals, and elevation was more in women of reproductive age group (30.8%). There was a statistically significant Spearman negative correlation between hemoglobin and HbA1C levels. Also, 16 patients had hyponatremia with a mean haemoglobin (Hb) of 4.8 g/dL and one patient had hyperkalemia with a mean Hb of 3.2 g/dL which was statistically non-significant. In this study haemoglobin and HbA1c had a statistically significant positive correlation with serum sodium and a negative correlation with serum potassium in moderate to severely iron-deficient anaemic patients, especially females of the reproductive age group.

Effect of iron deficiency anemia on blood levels of interleukin 6 and infection rates in children: a pilot study

Introduction: Iron deficiency is the most common micronutrient deficiency worldwide. Iron activates the growth and differentiation of immune cells and cytokine actions. Interleukin 6 is a pro-inflammatory cytokine that stimulates the differentiation of B lymphocytes into plasma cells and activates T lymphocytes. Our study aimed to evaluate the correlation between blood levels of iron and interleukin-6 (IL-6) and its impact on infection rates in children. Materials and methods: The study included 36 children. The serum concentration of IL-6, iron, and morphology parameters from a venous blood sample were assessed. An anonymous survey of children’s parents was conducted regarding the frequency of infections before and after the diagnosis of anemia. Results: In the study group, the levels of IL-6 were higher than in the control group and showed greater variability between individual patients. There was a statistically significant, negative correlation between IL-6 and iron levels within the study group (p = 0.012), and a decrease in the number of viral diarrheas after the diagnosis of anemia compared to the state before diagnosis (p = 0.041). There was no statistically significant change in the number of colds or the mean duration of infection (p = 0.144, p = 0.498), nor in the incidence of other infectious diseases and antibiotics intake in the study group before and after iron deficiency anemia diagnosis (p = 0.500, p = 0.219). Conclusions: IL-6 might play a role in iron deficiency anemia. Increased levels of IL-6 were shown not to correspond with visible changes in rates and the course of colds, but did result in a reduction in the frequency of viral diarrhea. Further research on a larger group of carefully selected patients is required to determine the effect of anemia on the immune system.

Effects of Iron Deficiency Anemia and its Treatment on Ghrelins, Obestatin and Heat Shock Protein 70

The impact of iron deficiency anemia (IDA) and its treatment on increased levels of heat shock protein 70 (HSP70) in settings with higher tissue stress induced by both ghrelin, which is both an antioxidant and a food intake stimulant, and also obestatin with opposing effects were investigated. The association of pica with these parameters was also examined. The study included 28 patients with IDA and 28 healthy controls. While acyl ve des-acyl ghrelin values were lower (p&lt;0.05) in IDA. With treatment, ghrelin levels climbed. In IDA, obestatin levels were higher than the control values (p&lt;0.05). With the IDA treatment, acyl and des-acyl Ghrelin levels increased. Contrarily, obestatin values fell down. The concentration of HSP 70 in IDA and during its therapy was above control values. Acyl, des-acyl ghrelin, obestatin, and HSP70 levels were increased in the pica group. In the pica group obestatin/acyl ghrelin ratio was comparatively higher (p&lt;0.05). In IDA decrease in ghrelin and an increase in obestatin levels are observed, while HSP 70 remains the same. An increase in the obestatin/acyl ghrelin ratio might be responsible for the pica disorder.

Iron supplementation for iron-deficiency anaemia

Background: In recent years, iron supplementation has increased significantly because of the damaging systemic effects of iron deficiency anaemia (IDA) being reported. The standard first-line therapy is oral iron tablets, with over 70% of recipients experiencing gastrointestinal adverse effects. Methods: This recent review of high-quality literature compares the effectiveness and adverse effects of tablet and liquid forms of iron supplementation in patients with IDA. Findings: The evidence to date indicates that both forms of iron supplementation are equally effective. However, the literature consistently and strongly supports the use of the liquid form of iron supplementation (ferrous sulfate) over the tablet form (ferrous sulphate or ferrous fumarate) in terms of adverse effects. Conclusions: Healthcare professionals should consider recommending the use of liquid iron formulation for the management of IDA and switch patients to this form if they experience gastrointestinal adverse effects. This may help to effectively manage IDA.

Effects of Iron Deficiency Anaemia in Pregnancy Outcome: A Single-Center Study

Background: Maternal anaemia especially iron deficiency anaemia has become a common problem worldwide. It is associated with adverse pregnancy outcomes like preterm birth, low birth weight and increases incidence of postpartum haemorrhage (PPH). Hence, this study aimed to find the association between maternal iron deficiency anaemia and pregnancy outcome. Methods: This retrospective cross-sectional study was conducted at the department of Obstetrics and Gynaecology in Kumudini Women's Medical College, Tangail, Bangladesh. The study was conducted during the period of July 2019-January 2020. A total of 93 pregnant women were found to be anemic through this whole trial. Result: In this study, 52% patients had mild level anaemia, 32% had moderate and 16% had severe anaemia. Patients who had severe anaemia significantly suffered from preeclampsia (46.7%), PPH (26.7%), need a blood transfusion during/within 24 hours of delivery (100%), prolonged labor (53.3%), fetal distress (53.3%), placenta praevia (86.7%), low birth weight (86.7%), preterm delivery (40.0%), stillbirth (13.3%) and early neonatal death (within 24 hours) (13.3%). All the complications were strongly associated with severity of anaemia (p value=0.000) except prolonged labour (p-value=0.04). Conclusion: This study concludes that iron deficiency anaemia has significant impact on pregnancy outcome. Hence, iron supplementation can be an effective way for improving IDA among the pregnant anaemic women. Also, proper antenatal care is important so that early detection and treatment of IDA can be possible.

Effect of Iron Deficiency Anemia on Hearing: Review Article

Effect of Iron Deficiency Anemia on Hearing: Review Article

Effect of Iron Deficiency Anemia on Glycated Albumin Levels: A Comparative Study in Nondiabetic Subjects with Iron Deficiency Anemia.

Objective Glycated hemoglobin A1c (HbA1c), used for monitoring glycemia control, is altered in iron deficiency anemia (IDA). Glycated albumin (GA) is considered an alternate biomarker to HbA1c. However, effect of IDA on GA needs to be studied. Materials and Methods Thirty nondiabetic cases with IDA and 30 healthy controls were included. Fasting plasma glucose (FPG), creatinine, urea, albumin, total protein, ferritin, iron, unsaturated iron binding capacity, hemoglobin (Hb), HbA1c, complete hemogram, and GA were estimated. Transferrin saturation and total iron binding capacity (TIBC) were calculated. Statistical analysis was done using unpaired two-tailed t -test/Mann-Whitney U -test and Pearson's correlation/Spearman-rank correlation, as appropriate. Results Total protein, albumin, Hb, iron, ferritin, and transferrin saturation were significantly lower while FPG, GA, TIBC, and HbA1c were significantly higher in cases compared to controls. HbA1C and GA have a significant negative correlation with iron, transferrin saturation, and ferritin. Significant negative correlations of GA with albumin ( r = -0.754; p < 0.001) and Hb ( r = -0.435; p = 0.001) and that of HbA1c with albumin ( r = -0.271; p = 0.03) and Hb ( r = -0.629; p < 0.001) while significant positive correlation of Hb with albumin ( r = 0.395; p = 0.002) and HbA1c with FPG ( r = 0.415; p = 0.001) were observed. Conclusion Low albumin levels increase plasma protein glycation, including albumin. Hence, elevated GA levels indicate false elevation of GA in scenario of lowered albumin observed in IDA, similar to HbA1c. Thus, using GA in diabetes mellitus with IDA should be avoided or used with caution to prevent potentially inappropriate treatment intensification and risk of hypoglycemia.

In-hospital mortality rate and predictors of 30-day readmission in patients with iron deficiency anemia and diastolic heart failure: A cross-sectional study

Introduction: There is currently strong evidence of the adverse effects of anemia on the prognosis of heart failure with reduced ejection fraction. Unfortunately, the data on the effects of anemia on a large sample of patients with diastolic heart failure (DHF) is lacking. In this study, we aimed to evaluate the effect of iron deficiency anemia on DHF readmission rates and its corresponding causes and burdens on the healthcare system. Methods: We utilized 2018 Nationwide readmission data and included patients aged ≥18 years with ICD-10 CM code indicating acute or acute chronic diastolic heart failure and iron deficiency anemia was included in the study. The primary outcome is 30-day readmission rates. Secondary outcomes were mortality rates, common causes of readmission, and healthcare utilization. Independent predictors for readmission were identified using cox regression analysis. Results: The total number of admissions in our study was 795,777. The mean age was 74.4 years (SD=13.7), and 63.54% were females. The 30-day readmission rate in patients with diastolic heart failure and iron deficiency anemia was 18.32 % vs. 16.01% in patients without anemia. The mortality rate at index admission and readmission was 3.62 % (2601) and 5.82 % (737), respectively. The most common cause of readmission was hypertensive heart and kidney disease with heart failure (17.74%). The independent predictors of readmission were age&lt;85 years, household income &lt;59000$/per year, Medicare and Medicaid insurance, higher Elixhauser comorbidities score, longer Length of stay during the index admission, discharge to a nursing home, hospital located in a large metropolitan area. The financial burden on healthcare for all the readmission was $837 million for 2018. Conclusion: The 30-day readmission rate in patients with diastolic heart failure and iron deficiency anemia is 18.32% in the year 2018. The mortality rate increased from 3.62 % to 5.82 % with readmission. The financial burden for readmission during that year was $837 million. Future studies are warranted to treat iron deficiency anemia to prevent readmissions in diastolic heart failure.

Залізодефіцитна анемія під час вагітності та наслідки, пов'язані з нею

Анотація: у статті узагальнено аргументи та контраргументи в рамках наукової дискусії щодо питання механізмів розвитку залізодефіцитної анемії. Основна мета цього дослідження це узагальнення інформації про вплив залізодефіцитної анемії під час вагітності та наслідків, пов’язаних з нею. Завдяки детальному вивченню літературних джерел, їхній систематизації та підходів до вирішення проблеми, було виявлено, що антенатальна анемія є фактором ризику материнської та перинатальної смертності, передчасних пологів, новонароджених з низькою масою тіла та післяпологових кровотеч. Анемія матері також може бути пов’язана з поганими результатами розвитку нервової системи дитини. Останні досягнення системного та плацентарного гомеостазу заліза можуть покращити терапевтичну ефективність шляхом зміни дози та частоти перорального прийому заліза. А внутрішньовенне введення заліза є безпечним засобом для швидкої корекції анемії матері. Актуальність дослідження даної патології полягає в тому, що вона багато в чому визначає перинатальну та материнську захворюваність. Однак, на сьогодні немає чіткого уявлення про особливості молекулярних та судинних механізмів залізодефіцитної анемії, тому це призводить до суперечностей у лікуванні таких вагітних жінок, що перешкоджає своєчасному, адекватному лікуванню та профілактиці. У дослідженні були використані методи бібліографічного та контент-аналізу літератури, семантичного групування, а також порівняльного підходу та синтезу відносно питань нових досліджень по особливостям механізмів розвитку залізодефіцитної анемії, гомеостазу заліза та поточних визначень ЗДА під час вагітності, несприятливі наслідки для матері та новонародженого, пов’язані з анемією, а також останні рекомендації щодо лікування ЗДА під час вагітності та післяпологового періоду. Офіційні документи, знайдені на веб-сайтах, були проаналізовані, а відповідна інформація згрупована та порівняна. В статті представлено результати досліджень, які засвідчили, що залізо відіграє ключову роль у нормальному і патологічному перебігу вагітності та впливає на розвиток новонародженого. Поглинання і метаболізм заліза суворо регулюються, і повне вивчення метаболізму заліза під час вагітності представляє інтерес для запобігання ускладнень у матері та плода. У цій роботі підкреслюється необхідність раннього виявлення дефіциту заліза. Крім того, є важливим лікувати дефіцит для забезпечення оптимального розвитку новонароджених. Наразі такі заходи, як пероральне або внутрішньовенне введення заліза, схоже, не працюють у масштабах, необхідних для досягнення цілей ВООЗ знизити поширеність анемії у жінок репродуктивного віку на 50%. Частково це може бути пов’язано з невизначеністю щодо того, як найкраще досліджувати, запобігати та лікувати материнську анемію. Розвиток нашого розуміння фізіології заліза привів до можливості значного покращення шляхом зміни стратегії дозування перорального заліза. Нові лабораторні показники заліза, такі як гепсидин, можуть в кінцевому підсумку допомогти керувати терапією дефіциту заліза, але нещодавнє дослідження не виявило жодної переваги від використання підходу скринінгу та лікування на основі гепсидину в порівнянні з рекомендованою схемою ВООЗ. Тому необхідні подальші дослідження щодо результатів, орієнтованих на пацієнта та економічної ефективності. Результати проведеного дослідження можуть бути корисними для лікарів первинної ланки, гінекологів, терапевтів.

Study of HbA1c in iron deficiency anemic non diabetic subjects

To study the effect of iron deficiency anemia on glycated hemoglobin (HbA1c) in non- diabetic Indian subjects. The present observational study was performed on minimum 100 patients attending General Medicine outpatient department. All patients presenting to General Medicine outpatient department fulfilled the inclusion and exclusion criteria enrolled in the study. An informed written consent was obtained from the patients. The detailed history was taken and necessary clinical examination was carried out in all patients. In the current study, patients with iron deficiency anaemia had a mean HbA1c of 5.86. The mean serum iron level in patients with Hb1Ac levels ranging from 4-5.6 was 24.25. The corresponding mean serum iron for HbA1c range 5.7-6.4 was 22.25. The corresponding mean serum iron for HbA1c levels greater than 6.5 was 21.96. According to the findings, there is an inverse relationship between HbA1c and mean serum iron levels, and this relationship is statistically significant (p0.05), i.e. mean serum iron decreases as HbA1c level increases. The present study concluded that the levels of HbA1c were increased significantly among patients with iron deficiency anemia. So, Iron deficiency anemia has to be kept in mind before using the HbA1c to diagnose diabetes.

Large-scale retrospective analyses of the effect of iron deficiency anemia on hemoglobin A1c concentrations

IntroductionHbA1c is a reliable biomarker for diagnosing and prognosis of diabetes, but many clinical scenarios and interfering factors can affect the test results. Any conditions that affect red cell turnover, such as iron-deficiency anemia (IDA), can lead to spurious HbA1c results. Reports on how IDA affects HbA1c concentrations are contradictory, and to understand better the association between HbA1c concentrations and IDA, we conducted a large-scale retrospective study. MethodsTest results for HbA1c concentrations were retrieved from the years 2015–2019. We evaluated over 12,000 patients with IDA and 21,000 patients without IDA. Patients were classified as having IDA if samples with below the age-based ranges for serum iron, ferritin, or transferrin iron saturation and above age-based ranges for transferrin iron-binding capacity or transferrin concentrations. Kruskal–Wallis statistical analyses method was used to test whether the two samples follow the same distribution and significance. ResultsThe median HbA1c concentration was 5.7% among IDA classified patients and 5.4% among normal samples (P < 0.001) for females. For males, the median HbA1c concentration was 6.0% among IDA classified patients and 5.6% among normal samples (P < 0.001). ConclusionPatients classified as IDA can have increased HbA1c concentrations than patients without IDA. Clinicians should consider IDA status before making therapeutic decisions based on HbA1c concentrations.

Iron-Deficiency Anemia in Women of Reproductive Age in Urban Areas of Quetta District, Pakistan.

Anemia is associated with poor health outcomes, and the prevalence of anemia is a significant public health indicator for both developed and developing countries. Iron-deficiency anemia (IDA) is the most common type of anemia, which often develops during pregnancy. A cross-sectional study was conducted in the urban areas of Quetta city among the women of reproductive age (15-49 years) to update the status of IDA in the region. The study participants (n = 216) were selected on a random basis, and the samples were further distributed by age. Overall, 75% of females were nonanemic, and among those that were anemic, 2% were severe, 13% were moderately, and 10% were mildly anemic. Among the IDA-affected women, 83% were non-pregnant. Age-wise distribution of IDA revealed no significant difference among different age groups, but numerically higher observations were recorded in the age groups of less than 30 years. The highest number of moderately IDA-affected women (15%) were in the age group 15-19 with the following IDA indicating parameters: hemoglobin 9.64 g/dl, mean corpuscular volume 63.11 fl, mean corpuscular hemoglobin 20.40%, red cell distribution 19.28%. This study will be beneficial for illustrating the requirement and the development of a program to raise extended awareness in the Quetta communities to overcome the negative health effects of IDA on the female population.

Evaluation of macular and optic disc radial peripapillary vessel density with optical coherence tomography angiography in iron deficiency anemia

PurposeTo investigate effect of iron deficiency anemia (IDA) on macular and radial peripapillary capillary (RPC) vascular changes by optical coherence tomography angiography (OCTA). MethodsThirty-three patients with IDA and 33 healthy controls were enrolled in the study. Foveal avascular zone (FAZ) area, macular superficial capillary plexus (SCP) and deep capillary plexus (DCP) vessel density and RPC vessel density were evaluated by the AngioVue Imaging System. Hemoglobin (Hb), hematocrit (Hct), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), red cell distribution width (RDW), serum iron, total iron-binding capacity (TIBC), serum ferritin and transferrin saturation values were also recorded. ResultsThere were no statistically significant differences between the two groups in terms of FAZ area and FAZ perimeter while foveal density (FD) was significantly decreased in the IDA group. Compared to control group, IDA group revealed significantly decreased macular vessel density in all macular regions except fovea in both SCP and DCP. RPC vessel density was significantly decreased in whole image, peripapillary and superior-hemifield area wihout RNFL thinning. Hemoglobin level was positively correlated with SCP whole and RPC whole vessel density and serum iron level was also positively correlated with SCP whole vessel density. ConclusionMacular and optic disc vessel density were reduced in IDA patients. OCTA may be useful in detecting retinal ischemia before clinically visible signs of retinopathy associated with IDA appear.

Prevalence and Associated Risk Factors of Iron Deficiency Anemia Among School Teenagers in Mbouda, Western Cameroon: A Cross Sectional Study

Teenagers are a particularly vulnerable age group to Iron Deficiency Anemia (IDA). This study aimed to determine the prevalence and associated risks factors of IDA among apparently healthy school teenagers in Mbouda, West-Cameroon. Blood samples, up to 778 were randomly collected from adolescents aged 10-19 years of four schools in Mbouda. For this cross-sectional study, participants collaborated to fill a questionnaire with us on socio-economic and demographic status. The methods of 24 hours recall, and dietary history were used to determine the dietary habits, the type of food and the consumed meal frequencies during a day. Appropriate indicators including hemoglobin and hematocrit, serum iron, ferritin, transferrin, and total iron binding capacity, transferrin saturation were determined using standard methods. Our findings showed that the prevalence of IDA was 82.4 % and 17.64 % in participants aged 13-19 years and 10-12 years respectively. High significant difference in the mean values of Serum Iron (p = 0.001), Serum ferritin (p&lt;0.001), TIBC (p&lt;0.001), CST (0.001) and Hemoglobin (p&lt;0.001, CI = 2) were observed in participants without IDA compared to those with IDA. The sociodemographic risk factors of IDA in school adolescents were sex [P = 0.001, OR = 0.39 (0.22–0.69)], residence areas [P = 0.001, OR = 3.30 (1.55–7.02)] and school sites [P = 0.002]. Consumption of vegetable [OR: 0.30 (0.17–0.54)], fruits, [OR: 0.26 (0.12–0.52)] and fats [OR: 0.33 (0.12–0.91)] significantly decreased the risk of IDA (p &lt;0.05), whereas the consumption of legumes [OR: 2.60 (1.57–4.32)] significantly increased the risk of IDA. This study suggested that IDA could be prevented by providing proper knowledge on the healthful diet including fats animal food sources, fruit and vegetables, improved lifestyle, and on the harmful effects of IDA to the teenager’s productivity.

Relationship between glycosylated hemoglobin and iron deficiency anemia: A common but overlooked problem

IntroductionBoth diabetes mellitus (DM) and iron deficiency anemia (IDA) are prevalent in every area of the world, and so, the possibility of these two diseases co-existing is also very high. It is our belief that clinical results of any correlation between iron status of the body and glycosylated haemoglobin (HbA1c) would be beneficial to many patients, therefore in this study, the effect of IDA on HbA1c was investigated. Materials – methodsA total of 146 patients with DM and IDA were evaluated prospectively. While the patients were administered 270 mg/day of ferrous sulphate (80 mg elemental iron) orally for three months for the treatment of IDA, no interventions were made for the treatment of DM. Patient levels of hemoglobin (Hb), hematocrit, red blood cells (RBC), mean corpuscular volume (MCV), platelet, white blood cells (WBC), serum iron, serum iron binding capacity (SIBC), ferritin, fasting plasma glucose (FPG), HbA1c, body mass index (BMI), C-reactive protein (CRP) values were measured at baseline and at the third month of treatment with iron, and were compared. ResultsThe median age of our patients was 45 (40–50) and median duration of diabetes was 3 years (1,75–5). While the baseline median Hb was 10.4 (mg/dL) (9.5–11.1), MCV was 74 (fL) (70.8–77), ferritin was 4 (ug/L) (3–6) at three months, Hb was measured at 12.6 (mg/dL) (12.1–13.2), MCV was measured at 82 (fL) (80–86), ferritin was measured at 15 (ug/L) (9–21.2) and was significantly higher compared to baseline values (p < 0.001). The baseline median HBA1c of patients was 7.09 ± 0.51 (%) and three month HBA1c was 6.69 ± 0.53 (%), which was significantly lower than when comparing baseline values with values at third month (p < 0.001). Baseline and three month values for FPG were 118 (mg/dL) (108–132) and 116 (mg/dL) (106–125) respectively, and there was no significant difference (p:0.07). A 2.2 mg/dL (1.5–3.5) increase in median Hb level accompanied a 0.4 % (0.2–0.6) decrease in median HbA1c levels (Spearman rho = −0.362; p < 0.001). ConclusionOur study has shown conclusivly that IDA is related to increased HbA1c concentrations and HbA1c decreases significantly following treatment with iron. IDA should be considered before making any decisions regarding diagnosis or treatment according to HbA1c.